Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Infect Control Hosp Epidemiol. 2021 Apr 23;43(2):212–217. doi: 10.1017/ice.2021.96

Table 3.

Outcomes of Influenza Patients With and Without Community-Onset Bacterial Coinfectiona

Variable Total (N = 4,313) Influenza Only (N = 3,868; 2.3%) Bacterial Coinfection (N = 445; 0.3%)
In hospital mortality, No. (%) 251 (5.8) 193 (5.0) 58 (13.0)
Length of stay, median (IQR) 5.0 (3.0–7.0) 4.0 (3.0–7.0) 6.0 (4.0–11.0)
Cost, median (IQR) 7,722 (4,906–13,792) 7,430 (4,725–12,953) 11,486 (6,667–22,825)
Late ICU (day2+)*, no. (%) 261 (8.0) 209/3,003 (7.0) 52/280 (18.6)
Late IMV (day2+)*, no. (%) 243 (6.1) 189/3,616 (5.2) 54/366 (14.8)
Late Vasopressor (day2+)*, no. (%) 200 (4.9) 149/3,720 (4.0) 51/283 (13.3)

Note. IQR, interquartile range (Q1–Q3); ICU, intensive care unit; IMV, intermittent mechanical ventilation.

*

Second day or after.

a

Differences are very highly statistically significant (P < .001) for all variables, by χ2 test for dichotomous variables and Wilcoxon rank sum test for length of stay and cost. Statistical significance does not imply clinical significance.